2nd Annual THINC Symposium welcomed distinguished leaders in drugging gene control from both academia and industry!

Leaders of studying and drugging gene control in both academia and industry were brought together to highlight research and further understanding in diseases of gene regulation. The 2nd Annual THINC Symposium was hosted April 11-12, 2019 at Baylor College of Medicine. Full agenda can be found here.

Left to right:  Damian Young, Ph.D. (BCM/THINC), Virginia Giuliani, Ph.D. (MD Anderson Cancer Center), Michael Erb, Ph.D. (Scripps Research Institute), Jonathan Brown, M.D., Ph.D. (Vanderbilt University), Charles Lin, Ph.D. (BCM/THINC), Angela Koehler, Ph.D. (MIT), Trey Westbrook, Ph.D. (BCM/THINC), Rhamy Zeid, Ph.D. (C4 Therapeutics), Robert Darnell, M.D., Ph.D. (The Rockefeller University), Kevin Weeks, Ph.D. (UNC- Chapel Hill), Calla Olson, Ph.D. (BCM/THINC), Kristen Karlin, Ph.D. (BCM/THINC), Michael Corsello, Ph.D. (BCM/THINC), Loic Samuel, Ph.D. (BCM/THINC)

Left to right: Damian Young, Ph.D. (BCM/THINC), Virginia Giuliani, Ph.D. (MD Anderson Cancer Center), Michael Erb, Ph.D. (Scripps Research Institute), Jonathan Brown, M.D., Ph.D. (Vanderbilt University), Charles Lin, Ph.D. (BCM/THINC), Angela Koehler, Ph.D. (MIT), Trey Westbrook, Ph.D. (BCM/THINC), Rhamy Zeid, Ph.D. (C4 Therapeutics), Robert Darnell, M.D., Ph.D. (The Rockefeller University), Kevin Weeks, Ph.D. (UNC- Chapel Hill), Calla Olson, Ph.D. (BCM/THINC), Kristen Karlin, Ph.D. (BCM/THINC), Michael Corsello, Ph.D. (BCM/THINC), Loic Samuel, Ph.D. (BCM/THINC)